Startup Diligence
Diligence report Healthcare and life sciences, Medicare Advantage, care delivery and healthcare software Private unicorn / late-stage Medicare Advantage and care-delivery company

Devoted Health

Devoted Health Startup Diligence Report

Continue diligence only with a data-room request focused on Medicare Advantage reimbursement, CMS compliance and star-rating sensitivity; Medical-loss-ratio, utilization and provider-network execution risk; Private capital/solvency and member concentration gaps. Public evidence supports category scale and product activity but does not verify underwriting-quality fundamentals.

Company profile

Devoted Health Startup Diligence Report

Devoted Health appears eligible as an active private unicorn based on public unicorn-list evidence and active company-owned public materials. The investability case remains highly dependent on private verification of financial quality, customer/member/merchant concentration, legal/regulatory posture and execution capacity.

Website
www.devoted.com
Sector
Healthcare and life sciences, Medicare Advantage, care delivery and healthcare software
Geography
United States; Waltham, Massachusetts with public plan/service-area footprint across 29 states
Stage
Private unicorn / late-stage Medicare Advantage and care-delivery company
Known aliases
Devoted Health, Devoted Health, Inc., Devoted Medical
Report version
1.0
Timezone
UTC

Executive summary

Strengths

  • Public unicorn-list evidence supports a latest known valuation of $12.90B.
  • Company-owned materials verify the public product model and market positioning.
  • Public company materials support scale indicators: members in 29 states (member count not public in reviewed sources); 29 U.S. states.

Risks

  • Medicare Advantage reimbursement, CMS compliance and star-rating sensitivity
  • Medical-loss-ratio, utilization and provider-network execution risk
  • Private capital/solvency and member concentration gaps

Gaps

  • Audited financials, ARR/revenue bridge, cash runway and cap table.
  • Customer/member/merchant concentration, retention/churn and unit economics.
  • Regulatory correspondence, litigation schedule, material contracts, insurance and IP assignments.
  • Org chart, headcount by function/location, compensation and retention/turnover data.

Recommended next steps

  • Request a complete financial, legal, customer and personnel data room before relying on valuation or scale claims.
  • Conduct customer/member/merchant or provider references appropriate to the sector.
  • Have counsel review regulatory permissions, open matters, material contracts and insurance coverage.

Risk register

high medium likelihood

R-DEV-001: Medicare Advantage reimbursement, CMS compliance and star-rating sensitivity

Medicare Advantage reimbursement, CMS compliance and star-rating sensitivity

Diligence request: Review regulator correspondence, compliance testing, audit findings, remediation plans and board risk materials.

high medium likelihood

R-DEV-002: Medical-loss-ratio, utilization and provider-network execution risk

Medical-loss-ratio, utilization and provider-network execution risk

Diligence request: Request audited financials, monthly management accounts, cohort economics, retention/churn and concentration schedules.

medium high likelihood

R-DEV-004: Competitive pricing and differentiation pressure

Devoted Health operates in a competitive market where larger incumbents and focused specialists can pressure pricing, distribution and customer acquisition costs.

Diligence request: Request win/loss analysis, pricing discount history, CAC by channel and competitive displacement metrics.

medium medium likelihood

R-DEV-003: Private capital/solvency and member concentration gaps

Private capital/solvency and member concentration gaps

Diligence request: Review operating KPIs, integration plans, roadmap dependencies, hiring plan and leadership retention.

medium unknown likelihood

R-DEV-005: Private data-room dependence for legal, IP and personnel conclusions

Public sources do not provide complete legal, IP, insurance, employment, stock-plan or compensation schedules.

Diligence request: Request counsel letters, docket searches, IP assignments, insurance policies, employment agreements and option-plan documents.

Chapter 01

01Financial Information

Public sources support Devoted Health's unicorn status and selected scale indicators, but audited statements, projections, tax positions, debt and ownership are private.

I.A Annual and quarterly financial information for the past three years

partially verified confidence: medium

Public sources support Devoted Health's unicorn status and selected scale indicators, but audited statements, projections, tax positions, debt and ownership are private.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section I.A: Annual and quarterly financial information for the past three years.
Public funding and valuation history
dateeventamount or valuationsourceverification statusdiligence caveat
2018-10-16Latest public unicorn valuation anchor$12.90BCB Insights and/or company sourceverifiedRequest primary financing documents and current 409A/fair-value support.
not_publicAudited annual and quarterly financialsnot_publicly_verifiableNo public financial statements reviewednot_publicly_verifiableRequest audited statements, management reports and monthly close package.
Revenue, ARR and unit-economic signals
metricpublic signalverification statusdiligence request
Revenue / ARRnot publicly verified in reviewed sourcesnot_publicly_verifiableRequest audited revenue, ARR waterfall, recognition policy and cohort detail.
Transaction/payment/member volumeMedicare Advantage enrollment and medical-cost metrics not publicnot_publicly_verifiableRequest monthly KPI export and reconciliation to revenue.
Gross margin / unit economicsnot_publicly_verifiablenot_publicly_verifiableRequest gross margin by product, contribution margin, CAC, payback and churn.
Funding and valuation timeline Public financing and valuation anchors with private-data gaps.
Public valuation trajectory Line chart of available valuation anchors, with null values where private records are needed.

I.B Financial Projections

inconclusive confidence: medium

Public sources support Devoted Health's unicorn status and selected scale indicators, but audited statements, projections, tax positions, debt and ownership are private.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section I.B: Financial Projections.

I.C Capital Structure

not publicly verifiable confidence: low

Public sources support Devoted Health's unicorn status and selected scale indicators, but audited statements, projections, tax positions, debt and ownership are private.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section I.C: Capital Structure.
Capital structure and ownership snapshot
stakeholderpublic positionevidencediligence caveat
Named investors from unicorn list| Devoted Health | $12.90 | 10/16/2018 | United States | Waltham | Healthcare & Life Sciences | Andreessen Horowitz, F-Prime Capital, Venrock |CB Insights candidate rowConfirm share classes, ownership percentages, preferences, warrants and side letters.
Founders/managementnot_publicly_verifiablePublic sources do not disclose current ownership.Request cap table and option plan.
Debt/credit providersnot_publicly_verifiableNo complete debt schedule in reviewed public sources.Request debt, covenant and off-balance-sheet liability schedule.

I.D Other financial information

not publicly verifiable confidence: low

Public sources support Devoted Health's unicorn status and selected scale indicators, but audited statements, projections, tax positions, debt and ownership are private.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section I.D: Other financial information.
Chapter 02

02Products

Company materials verify the public product families, while pricing, profitability, roadmap cost and product-level growth remain private.

II.A Description of each product

partially verified confidence: medium

Company materials verify the public product families, while pricing, profitability, roadmap cost and product-level growth remain private.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section II.A: Description of each product.
Product / SKU matrix
productaudiencepublic evidenceverification status
Medicare Advantage plansPublic target segment from company positioningCompany product/about pagesverified
Member Service GuidePublic target segment from company positioningCompany product/about pagesverified
Provider network accessPublic target segment from company positioningCompany product/about pagesverified
Devoted Medical virtual/in-home carePublic target segment from company positioningCompany product/about pagesverified
Devoted software platformPublic target segment from company positioningCompany product/about pagesverified
Provider portal/Availity workflowsPublic target segment from company positioningCompany product/about pagesverified
Pricing and packaging comparison
offeringpublic pricing signalcompetitor referencediligence gap
Medicare Advantage plansnot fully public in reviewed sourcesUnitedHealthcare Medicare AdvantageRequest price book, discounting and margin by SKU.
Member Service Guidenot fully public in reviewed sourcesHumanaRequest attach rates, expansion ARR and churn by package.
Enterprise / platform contractsnot_publicly_verifiableAetna / CVS HealthRequest contract-level pricing and implementation fees.
Product architecture / dependency map Public product families connected to customer/regulated infrastructure dependencies.
Chapter 03

03Customer Information

Public sources disclose customer/member/merchant scale or examples, but concentration, revenue contribution and relationship status are private.

III.A Top customers by application

partially verified confidence: medium

Public sources disclose customer/member/merchant scale or examples, but concentration, revenue contribution and relationship status are private.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section III.A: Top customers by application.
Public customers, members or merchant segments
customer or segmentuse casepublic evidenceverification statusgap
Medicare Advantage members in 29 statesPublicly described or inferable target/use caseCompany public sourcepartially_verifiedRevenue contribution, contract term and renewal status not public.
Local provider networksPublicly described or inferable target/use caseCompany public sourcepartially_verifiedRevenue contribution, contract term and renewal status not public.
BrokersPublicly described or inferable target/use caseCompany public sourcepartially_verifiedRevenue contribution, contract term and renewal status not public.
CMS-regulated plan marketsPublicly described or inferable target/use caseCompany public sourcepartially_verifiedRevenue contribution, contract term and renewal status not public.

III.B Strategic relationships

inconclusive confidence: medium

Public sources disclose customer/member/merchant scale or examples, but concentration, revenue contribution and relationship status are private.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section III.B: Strategic relationships.
Strategic relationships and partnerships
partnernaturepublic evidencerisk or gap
Local doctors and hospitalsPublicly referenced partner/regulatory/market relationshipCompany public sourceEconomic terms and obligations not public.
AvailityPublicly referenced partner/regulatory/market relationshipCompany public sourceEconomic terms and obligations not public.
Provider portal usersPublicly referenced partner/regulatory/market relationshipCompany public sourceEconomic terms and obligations not public.
CMS / Medicare Advantage program contextPublicly referenced partner/regulatory/market relationshipCompany public sourceEconomic terms and obligations not public.

III.C Revenue by customer

not publicly verifiable confidence: low

Public sources disclose customer/member/merchant scale or examples, but concentration, revenue contribution and relationship status are private.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section III.C: Revenue by customer.
Customer / partner concentration disclosure chart Bar chart showing disclosed public scale and missing concentration data.

III.D Significant relationships severed within the last two years

not publicly verifiable confidence: low

Public sources disclose customer/member/merchant scale or examples, but concentration, revenue contribution and relationship status are private.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section III.D: Significant relationships severed within the last two years.

III.E Top suppliers

inconclusive confidence: medium

Public sources disclose customer/member/merchant scale or examples, but concentration, revenue contribution and relationship status are private.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section III.E: Top suppliers.
Supplier and infrastructure dependency snapshot
supplier or dependencyrolepublic evidenceconcentration risk
Provider networksOperational dependencyPublicly stated or inferred from product modelRequires vendor spend, SLA and resiliency review.
Claims/eligibility technology providersOperational dependencyPublicly stated or inferred from product modelRequires vendor spend, SLA and resiliency review.
Pharmacy and DME networks - not fully itemized publiclyOperational dependencyPublicly stated or inferred from product modelRequires vendor spend, SLA and resiliency review.
Telemedical/in-home clinical resourcesOperational dependencyPublicly stated or inferred from product modelRequires vendor spend, SLA and resiliency review.
Chapter 04

04Competition

The competitive landscape is crowded; public sources support product positioning, but win/loss, pricing pressure and market share need private validation.

IV.A Competitive landscape by market segment

partially verified confidence: medium

The competitive landscape is crowded; public sources support product positioning, but win/loss, pricing pressure and market share need private validation.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section IV.A: Competitive landscape by market segment.
Competitor comparison matrix
competitorsegmentproduct overlaptarget differentiatorsource
UnitedHealthcare Medicare AdvantageHealthcare and life sciences, Medicare Advantage, care delivery and healthcare softwareOverlaps with one or more target offeringsRequires win/loss validation; public positioning emphasizes target product model and scale.Analyst competitor map using public market knowledge and target positioning.
HumanaHealthcare and life sciences, Medicare Advantage, care delivery and healthcare softwareOverlaps with one or more target offeringsRequires win/loss validation; public positioning emphasizes target product model and scale.Analyst competitor map using public market knowledge and target positioning.
Aetna / CVS HealthHealthcare and life sciences, Medicare Advantage, care delivery and healthcare softwareOverlaps with one or more target offeringsRequires win/loss validation; public positioning emphasizes target product model and scale.Analyst competitor map using public market knowledge and target positioning.
Cigna HealthcareHealthcare and life sciences, Medicare Advantage, care delivery and healthcare softwareOverlaps with one or more target offeringsRequires win/loss validation; public positioning emphasizes target product model and scale.Analyst competitor map using public market knowledge and target positioning.
Alignment HealthcareHealthcare and life sciences, Medicare Advantage, care delivery and healthcare softwareOverlaps with one or more target offeringsRequires win/loss validation; public positioning emphasizes target product model and scale.Analyst competitor map using public market knowledge and target positioning.
Clover HealthHealthcare and life sciences, Medicare Advantage, care delivery and healthcare softwareOverlaps with one or more target offeringsRequires win/loss validation; public positioning emphasizes target product model and scale.Analyst competitor map using public market knowledge and target positioning.
Basis-of-competition scoring
axistarget public positioncompetitor pressureevidence strength
Product breadthMedicare Advantage plans, Member Service Guide, Provider network access, Devoted Medical virtual/in-home careHighmedium
Distribution / partnershipsLocal doctors and hospitals, Availity, Provider portal usersHighmedium
Pricing / unit economicsnot_publicly_verifiableHighlow
Competitive market map Qualitative positioning of target and competitors.
Chapter 05

05Marketing, Sales, and Distribution

Public channels show direct, web, partner or regulated-market distribution signals, but CAC, pipeline conversion and sales productivity are not public.

V.A Strategy and implementation

partially verified confidence: medium

Public channels show direct, web, partner or regulated-market distribution signals, but CAC, pipeline conversion and sales productivity are not public.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section V.A: Strategy and implementation.
Distribution channels and GTM motions
channelregion or segmentpublic evidencegap
Direct web/self-servePublic website markets productsCompany siteConversion, CAC and sales productivity not public.
Partners / ecosystemLocal doctors and hospitals, Availity, Provider portal usersCompany pages/newsroomPartner-sourced revenue and obligations not public.
Enterprise or regulated-market salesLarger customers/providers/merchants depending on companyCompany positioningPipeline and sales-cycle data not public.
Public marketing-signal summary
signalpublic evidenceinterpretationdiligence gap
Scale headlinemembers in 29 states (member count not public in reviewed sources)Supports market momentum but not cohort quality.Request retention and cohort proof.
Product breadthMedicare Advantage plans, Member Service Guide, Provider network access, Devoted Medical virtual/in-home care, Devoted software platformSupports cross-sell thesis.Request attach-rate and gross-margin proof.
Geographic footprint29 U.S. statesSupports expansion narrative.Request revenue by geography and regulatory status by entity.
GTM channel disclosure chart Bar chart of GTM channel weights, with public signals but private weights.

V.B Major Customers

inconclusive confidence: medium

Public channels show direct, web, partner or regulated-market distribution signals, but CAC, pipeline conversion and sales productivity are not public.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section V.B: Major Customers.

V.C Principal avenues for generating new business

inconclusive confidence: medium

Public channels show direct, web, partner or regulated-market distribution signals, but CAC, pipeline conversion and sales productivity are not public.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section V.C: Principal avenues for generating new business.

V.D Sales force productivity model

not publicly verifiable confidence: low

Public channels show direct, web, partner or regulated-market distribution signals, but CAC, pipeline conversion and sales productivity are not public.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section V.D: Sales force productivity model.

V.E Ability to implement marketing plan with current and projected budgets

not publicly verifiable confidence: low

Public channels show direct, web, partner or regulated-market distribution signals, but CAC, pipeline conversion and sales productivity are not public.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section V.E: Ability to implement marketing plan with current and projected budgets.
Chapter 06

06Research and Development

Product and operational capabilities are visible at a high level, but technical architecture, R&D budget, roadmap and development risks require data-room evidence.

VI.A Description of R&D organization

partially verified confidence: medium

Product and operational capabilities are visible at a high level, but technical architecture, R&D budget, roadmap and development risks require data-room evidence.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VI.A: Description of R&D organization.
Key R&D, product and operating personnel signals
name or rolerolepublic evidencediligence gap
Todd ParkCo-founderAbout page names founding brotherRequest org chart, employment terms, retention risk and succession plan.
Ed ParkCo-founderAbout page names founding brotherRequest org chart, employment terms, retention risk and succession plan.
Devoted Medical cliniciansCare-delivery organizationCompany describes in-house cliniciansRequest org chart, employment terms, retention risk and succession plan.
Member Service GuidesMember support organizationCompany describes guide modelRequest org chart, employment terms, retention risk and succession plan.
R&D and operations capability map Map public product, technology and regulated operations domains.

VI.B New Product Pipeline

inconclusive confidence: medium

Product and operational capabilities are visible at a high level, but technical architecture, R&D budget, roadmap and development risks require data-room evidence.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VI.B: New Product Pipeline.
Public product / research pipeline
project or themestatussourceverification
Medicare Advantage planscommercially marketedCompany pagesverified
Member Service Guidecommercially marketed or publicly positionedCompany pagesverified
Forward roadmap, R&D cost and release datesnot_publicly_verifiablePrivate roadmap requirednot_publicly_verifiable
Chapter 07

07Management and Personnel

Public leadership or role signals are limited; full org chart, compensation, retention and turnover data are not public.

VII.A Organization Chart

partially verified confidence: medium

Public leadership or role signals are limited; full org chart, compensation, retention and turnover data are not public.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VII.A: Organization Chart.
Public leadership / role org chart Org chart using only public leadership or role evidence.

VII.B Historical and projected headcount by function and location

inconclusive confidence: medium

Public leadership or role signals are limited; full org chart, compensation, retention and turnover data are not public.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VII.B: Historical and projected headcount by function and location.
Headcount and hiring signals
functionregionpublic evidencesource
Leadership / corporateUnited States; Waltham, Massachusetts with public plan/service-area footprint across 29 statesPublic leadership or company narrative exists; complete org chart private.Company public materials
Product / engineering / clinical / operationsnot fully publicImplied by product model; headcount by function unavailable.Analyst gap
Sales / support / compliancenot fully publicPublic support/compliance signals exist where stated; staffing levels private.Analyst gap
Headcount trend disclosure chart Headcount chart intentionally marks missing public anchors.

VII.C Senior management biographies

inconclusive confidence: medium

Public leadership or role signals are limited; full org chart, compensation, retention and turnover data are not public.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VII.C: Senior management biographies.
Senior management roster
nameroletenure or contextsource
Todd ParkCo-founderAbout page names founding brotherCompany public materials
Ed ParkCo-founderAbout page names founding brotherCompany public materials
Devoted Medical cliniciansCare-delivery organizationCompany describes in-house cliniciansCompany public materials
Member Service GuidesMember support organizationCompany describes guide modelCompany public materials

VII.D Compensation arrangements

not publicly verifiable confidence: low

Public leadership or role signals are limited; full org chart, compensation, retention and turnover data are not public.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VII.D: Compensation arrangements.

VII.E Incentive stock plans

not publicly verifiable confidence: low

Public leadership or role signals are limited; full org chart, compensation, retention and turnover data are not public.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VII.E: Incentive stock plans.

VII.F Significant employee relations problems, past or present

not publicly verifiable confidence: low

Public leadership or role signals are limited; full org chart, compensation, retention and turnover data are not public.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VII.F: Significant employee relations problems, past or present.

VII.G Personnel Turnover

not publicly verifiable confidence: low

Public leadership or role signals are limited; full org chart, compensation, retention and turnover data are not public.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VII.G: Personnel Turnover.
Departures and turnover signals
signalpublic statusverification statusdiligence request
Executive departuresNo complete public departure schedule in reviewed sourcesnot_publicly_verifiableRequest executive turnover and retention schedule.
Employee relations mattersNo complete public employee-relations schedule in reviewed sourcesnot_publicly_verifiableRequest HR claims, investigations and settlement schedule.
Chapter 08

08Legal and Related Matters

Public legal/regulatory signals are incomplete; counsel schedules, regulatory correspondence, insurance, IP and material contracts require direct review.

VIII.A Pending lawsuits against the Company

not publicly verifiable confidence: low

Public legal/regulatory signals are incomplete; counsel schedules, regulatory correspondence, insurance, IP and material contracts require direct review.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VIII.A: Pending lawsuits against the Company.
Pending lawsuits against the company
casecourt or agencystatussource
No comprehensive public docket search completed in this standard screenMultiple jurisdictions possiblenot_publicly_verifiableRequest counsel litigation schedule and docket search.
Material threatened claimsnot_publicly_verifiablenot_publicly_verifiableRequest counsel letter.

VIII.B Pending lawsuits initiated by Company

not publicly verifiable confidence: low

Public legal/regulatory signals are incomplete; counsel schedules, regulatory correspondence, insurance, IP and material contracts require direct review.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VIII.B: Pending lawsuits initiated by Company.
Pending lawsuits initiated by company
defendantcourt or agencystatussource
No comprehensive public initiated-litigation schedule in reviewed sourcesMultiple jurisdictions possiblenot_publicly_verifiableRequest counsel litigation schedule and docket search.
IP, contract or collections disputesnot_publicly_verifiablenot_publicly_verifiableRequest legal matter schedule.

VIII.C Environmental and employee safety issues and liabilities

inconclusive confidence: medium

Public legal/regulatory signals are incomplete; counsel schedules, regulatory correspondence, insurance, IP and material contracts require direct review.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VIII.C: Environmental and employee safety issues and liabilities.

VIII.D Material patents, copyrights, licenses, and trademarks

inconclusive confidence: medium

Public legal/regulatory signals are incomplete; counsel schedules, regulatory correspondence, insurance, IP and material contracts require direct review.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VIII.D: Material patents, copyrights, licenses, and trademarks.
Material IP, licenses and compliance assets
asset or licensejurisdictionstatussource
CMS-regulated Medicare Advantage plan operationsFederal and state healthcare regulationPublic plan and policy pages indicate regulated MA operationsEC-DEV-006
Provider authorizations and claimsPrior authorization, claims disputes and provider portal workflowsProvider page describes authorizations and claims processesEC-DEV-005
Privacy and nondiscrimination resourcesHealthcare privacy and member-rights obligationsPublic policy navigation lists privacy, nondiscrimination, member rights and complianceEC-DEV-006

VIII.E Insurance coverage and material exposures

not publicly verifiable confidence: low

Public legal/regulatory signals are incomplete; counsel schedules, regulatory correspondence, insurance, IP and material contracts require direct review.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VIII.E: Insurance coverage and material exposures.

VIII.F Material contracts

not publicly verifiable confidence: low

Public legal/regulatory signals are incomplete; counsel schedules, regulatory correspondence, insurance, IP and material contracts require direct review.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VIII.F: Material contracts.

VIII.G Regulatory agency problems

inconclusive confidence: medium

Public legal/regulatory signals are incomplete; counsel schedules, regulatory correspondence, insurance, IP and material contracts require direct review.

Evidence gaps

  • Data-room materials are required for full verification of this checklist section.

Hidden risks

  • Public materials may overstate scale or understate operational/legal complexity because detailed company records are unavailable.

Follow-up questions

  • Provide company records addressing checklist section VIII.G: Regulatory agency problems.
Regulatory / agency actions and compliance signals
agency or frameworkaction or obligationdate or statusdiligence request
Federal and state healthcare regulationCMS-regulated Medicare Advantage plan operationsPublic plan and policy pages indicate regulated MA operationsRequest underlying filings, approvals, correspondence and remediation evidence.
Prior authorization, claims disputes and provider portal workflowsProvider authorizations and claimsProvider page describes authorizations and claims processesRequest underlying filings, approvals, correspondence and remediation evidence.
Healthcare privacy and member-rights obligationsPrivacy and nondiscrimination resourcesPublic policy navigation lists privacy, nondiscrimination, member rights and complianceRequest underlying filings, approvals, correspondence and remediation evidence.
Legal and regulatory timeline Public legal/regulatory/compliance signals plus diligence requests.
Risk heatmap Severity/likelihood view of the top risk register.

Evidence

Evidence claims
IDClaimStatusSources
EC-DEV-001 CB Insights lists Devoted Health as a current private unicorn at a $12.90B valuation. verified medium SRC-DEV-001
EC-DEV-002 Devoted Health says it was founded in 2017 by Todd and Ed Park and offers Medicare Advantage plans. verified high SRC-DEV-002
EC-DEV-003 Devoted describes an all-in-one healthcare service for Medicare beneficiaries with five components. verified high SRC-DEV-002SRC-DEV-005
EC-DEV-004 Devoted publicly states it serves members in 29 states. verified high SRC-DEV-002
EC-DEV-005 Devoted provider operations use Availity and the Devoted Provider Portal for eligibility, claims and authorizations. verified high SRC-DEV-003SRC-DEV-005
EC-DEV-006 Devoted maintains public policy and compliance resources. partially verified medium SRC-DEV-004
EC-DEV-007 Audited financial statements, medical-loss-ratio detail, CMS contract economics, cap table, litigation schedule and member-level retention are not public. not publicly verifiable high SRC-DEV-001SRC-DEV-002SRC-DEV-003SRC-DEV-004
Sources
IDPublisherTitleAccessed
SRC-DEV-001 CB Insights CB Insights Global Unicorn Club - Devoted Health row 2026-06-13
SRC-DEV-002 Devoted Health About Us | Devoted Health 2026-06-13
SRC-DEV-003 Devoted Health Providers | Devoted Health 2026-06-13
SRC-DEV-004 Devoted Health Devoted Health policy/navigation pages 2026-06-13
SRC-DEV-005 Devoted Health Our Technology | Devoted Health 2026-06-13

Disclaimer

This report is a public-evidence diligence snapshot, not investment advice. Important financial, legal, technical, and contractual facts remain non-public and should be verified directly with management and primary documents before any investment decision.